SANDERS MACHELLE

BCRX

SANDERS MACHELLE serves as Director at BioCryst Pharmaceuticals, Inc. (BCRX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

3 trades

$128.6K

Net Position

Net Seller

$128.6K

Companies Traded

BCRX

Active Period

Jun 2023 – Nov 2025

3 total trades

Most Recent

Sell BCRX

Nov 13, 2025 · $68.5K

SANDERS MACHELLE's Insider Trading at BioCryst Pharmaceuticals, Inc. (BCRX)

Buys

0 · $0.00

Sells

3 · $128.6K

Total Shares Bought

Total Shares Sold

18,289

BCRX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value
Nov 13, 2025	Sell	9,600	$7.14	$68.5K
Jun 17, 2024	Sell	4,689	$6.00	$28.1K
Jun 13, 2023	Sell	4,000	$7.98	$31.9K

Related Insiders

Alane P Barnes

officer: Chief Legal Officer

BCRXSell · Mar 18, 2026

Charles K Gayer

President and CCO

BCRXSell · Dec 19, 2025

Jon P Stonehouse

Chief Executive Officer

BCRXSell · Dec 19, 2025

HEGGIE THERESA

Director

BCRXSell · Aug 13, 2025

Helen M. Thackray

Chief R&D Officer

BCRXSell · Mar 31, 2025

Explore More Insider Trading Data

BCRX Insider Trading Activity

View all insider trades at BioCryst Pharmaceuticals, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity